Litcius/Paper detail

Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial

Yi Li, Zhenyang Liang, Lei Qin, Mian Wang, Xianzhao Wang, Huanyi Zhang, Yin Liu, Yan Li, Zhisheng Jia, Limin Liu, Hongyan Zhang, Jun Luo, Songwu Dong, Jincheng Guo, Hengqing Zhu, Shengli Li, Haijun Zheng, Lijun Liu, Yanqing Wu, Yiming Zhong, Miaohan Qiu, Yaling Han, Gregg W. Stone

2022The Lancet114 citationsDOI

Topics & Concepts

BivalirudinMedicineConventional PCIPercutaneous coronary interventionMyocardial infarctionHeparinInternal medicineCardiologyClinical endpointLoading doseRandomized controlled trialAcute Myocardial Infarction ResearchHeparin-Induced Thrombocytopenia and ThrombosisMechanical Circulatory Support Devices